The company received positive results from the phase 2 clinical study and that's what makes this stock went supernova. But 150%+ spike in two days just because of the positive results from their drug test NOT even a FDA approval, seems over-extended to me. Plus, the CEO and insiders sold their shares around $10-12 on the first day of its spike that means the insiders don't even think that their company should worth $17 or higher, it just my opinion. While I'm typing this the stock drop to $13

I shorted this $1 billion dollar biopharmaceutical company because the daily chart of the RSI was around 80 which means it was over-extended after several days of spiking, today is its most choppiest day since it ran up from the $10 to $15, and there were the huge wall of sellers at $15. So, that was the reason why I shorted this stock. I covered too soon again my goal was to make 5% on the down side but because this is $1 billion dollar company so I got scared LOL.

"Buy the rumor, sell the news" this is the logic that I'm using to short this stock. As you can see on the chart, $AVEO has been up a tons due to the rumor that their cancer drug will get approval in Europe, the news is old and because of this news that hype the stock. I shorted this stock twice back in July because they were over-extended. I shorted $AVEO just one day before they release the approval news. I was right on track, the stock crashed when the market open but I cover it way too soon.

I shorted this earnings winner just because its over-extended. I already know that its a earnings winner its risky to short but all I wanted was just a small pull back. My goal was to cover @4.45 but because its a earnings winner like I said, there are possibility that it could squeeze the short sellers. I didn't want to be too greedy so I locked into my profits @4.48 just a few cents higher than my goal. By the end of the day the stocks faded all the way too @4.15 and I covered it way too fast.

The company reported a solid progress in the second quarter of 2017 and capping off a pretty good first half of the year. Although sales are down, the company's bet on lower-cost solar production is resulting in improved gross margin and cash generation. Then again, the company is still losing money and that was the reason why I shorted this stocks. But, I entered my short way too early and got squeezed. I should've wait on the next day. Although, I still making a little profits.

If you look at the daily chart, its a down-trending stock,. But I was shorting this way too early @2.10 and the stock was spiking all the way to @2.81 and it came back down to the support @2.25-2.30, it held the support there for 4 days before it crashed. It was scary to holding the short because the ER was scheduled next week 8/1, oil/nature gas price seems like it will rebound, and it held the support there. I was almost gave up and cover all my shares when I saw it hold the support @2.25-2.30

I shorted this dead cat bounce on its second green day. The company reported a surprise fiscal first-quarter loss. Separately, the company said it had failed to comply with certain covenants in the Cerberus credit facility. Plus, the stock just hit 20-years low, it shows that this company is in trouble right now and I'm looking forward to re-short this stocks into any further big spikes.

This is the second within a week that I made money out of this over-extended stocks. I re-shorted in the morning @3.10 and covered it @2.95 after it was fading down. Before market closed I was hesitate to re-short this stock for the 3rd time because it closed strong but couldn't break above the resistance. Pre-market on the next day it broke above the resistance @3.20 but then it crashed since market opened all the way down to @2.75. I regret it a little bit but it was okay since I nailed it!

I shorted this stocks because It went up from $0.70 to $2s within 4 days and the news was not that great neither. The news that caused this stocks went supernova was that the company got about $14 millions funds and it will be using for the operation in 2018, also one of their drugs got recommended to be approved in EU. But they have to compete against $EXEL the $7 billions company, so it was not easy. I will be looking forward to re-short this stocks if it can't break above @2.30.

The reason that this stocks spiked was because they had the new CEO and the company laid off half of their employees to reduce the cost. And I thought that the news was not that great, it doesn't make any sense for the stocks to have such a big spikes so I thought it was just a pump that was the reason I shorted this stocks. It squeeze up to @1.96 in the midday and crashed all the way down to @1.69 by the end of the day so I covered my short @1.71